These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11086339)

  • 1. Genetics and molecular biology.
    Baralle M; Baralle FE
    Curr Opin Lipidol; 2000 Dec; 11(6):653-6. PubMed ID: 11086339
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein A-I-containing lipoproteins and atherosclerosis.
    Leroy A; Dallongeville J; Fruchart JC
    Curr Opin Lipidol; 1995 Oct; 6(5):281-5. PubMed ID: 8520850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse cholesterol transport: high-density lipoprotein's magnificent mile.
    Toth PP
    Curr Atheroscler Rep; 2003 Sep; 5(5):386-93. PubMed ID: 12911849
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of HDL and its modulators in the development of diabetes.
    Ng DS; Saw NM
    Curr Opin Lipidol; 2012 Apr; 23(2):167-8. PubMed ID: 22418575
    [No Abstract]   [Full Text] [Related]  

  • 5. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
    Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
    Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
    Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
    Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase.
    Bérard AM; Föger B; Remaley A; Shamburek R; Vaisman BL; Talley G; Paigen B; Hoyt RF; Marcovina S; Brewer HB; Santamarina-Fojo S
    Nat Med; 1997 Jul; 3(7):744-9. PubMed ID: 9212100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoprotein A-I].
    Nakamura T; Tsujinaka K; Kashiwagi A
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():96-100. PubMed ID: 11351710
    [No Abstract]   [Full Text] [Related]  

  • 13. High density lipoproteins and coronary heart disease. Future prospects in gene therapy.
    Fruchart JC; Duriez P
    Biochimie; 1998 Feb; 80(2):167-72. PubMed ID: 9587674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro glycation of human apolipoprotein AI reduces its efficiency in lecithin:cholesterol acyltransferase activation.
    Gugliucci A; Stahl AJ
    Clin Chim Acta; 1991 Dec; 204(1-3):37-42. PubMed ID: 1819472
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer.
    Calabresi L; Franceschini G; Burkybile A; Jonas A
    Biochem Biophys Res Commun; 1997 Mar; 232(2):345-9. PubMed ID: 9125178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of exchangeable apolipoprotein function.
    Narayanaswami V; Ryan RO
    Biochim Biophys Acta; 2000 Jan; 1483(1):15-36. PubMed ID: 10601693
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
    Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
    Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin: cholesterol acyltransferase. An exercise in comparative biology.
    Glomset JA
    Prog Biochem Pharmacol; 1979; 15():41-66. PubMed ID: 224398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.